placebo + varenicline
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Smoking Cessation
Conditions
Smoking Cessation
Trial Timeline
Sep 1, 2008 → Dec 1, 2009
NCT ID
NCT00691483About placebo + varenicline
placebo + varenicline is a approved stage product being developed by Pfizer for Smoking Cessation. The current trial status is completed. This product is registered under clinical trial identifier NCT00691483. Target conditions include Smoking Cessation.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01532232 | Pre-clinical | Terminated |
| NCT01413516 | Phase 2 | Completed |
| NCT00691483 | Approved | Completed |
| NCT00709696 | Pre-clinical | Completed |
| NCT00282984 | Phase 3 | Completed |
Competing Products
20 competing products in Smoking Cessation